Skip to main content
VREX
NASDAQ Manufacturing

Varex Reports Q3 FY26 Results: $0.37 GAAP EPS, Cancels Call Amid Teledyne Deal

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$18.566
Mkt Cap
$522.461M
52W Low
$6.96
52W High
$14.565
52W Position info
167% above low
Off High info
at 52W high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

VREX has more than doubled off its 52-week low of $6.96.

Summary

Varex Imaging reported Q3 FY26 preliminary results with GAAP EPS of $0.37 and $21M in operating cash flow. The company cancelled its earnings call and suspended guidance due to the pending acquisition by Teledyne.


Key Events · Earnings and Guidance · VREX

  • Q3 FY26 Results Beat Prior Year

    Revenues of $211M, GAAP net income of $0.37 per diluted share, and non-GAAP net income of $0.31 per diluted share, compared to a net loss of $2.15 per share in Q3 FY25.

  • Tariff Refunds Boost Profitability

    Received $17M in IEEPA tariff refunds, with a $7M revenue reduction for customer reimbursements, resulting in a net $10M gross profit increase.

  • Strong Cash Generation

    Cash flow from operations was $21M, though cash and equivalents declined to $99M from $155M at FY25 end due to debt refinancing and inventory build.

  • Earnings Call Cancelled, Guidance Withdrawn

    Due to the pending acquisition by Teledyne Technologies, Varex cancelled its Q3 earnings call and will not provide financial guidance, a customary practice during such transactions.


Analysis · VREX · Manufacturing

Varex delivered a strong quarter with GAAP EPS of $0.37, up from a loss last year, driven by industrial growth and tariff refunds. The cancellation of the earnings call and withdrawal of guidance signal the pending Teledyne acquisition is on track, making near-term operational performance secondary to deal completion.

At the time of this filing, VREX was trading at $18.57 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $522.5M. The 52-week trading range was $6.96 to $14.57. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VREX - Latest Insights

VREX
May 07, 2026, 4:22 PM EDT
Filing Type: 10-Q
Importance Score:
8
VREX
May 07, 2026, 4:11 PM EDT
Filing Type: 8-K
Importance Score:
7
VREX
May 07, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
VREX
Mar 16, 2026, 8:31 AM EDT
Filing Type: 8-K
Importance Score:
8
VREX
Feb 10, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
7